Romla
8 years agoMember
Prolia reduces risk of bc recurrence and helps prevent fractures for those on AIs
Hi ladies me again - just a copy of an email to Christian Porter MP to explain why Prolia should be PBS price for bc patients.Hopefully is clearer explanation
Many women who have estrogen positive breast cancer - the most common form of breast cancer- are prescribed hormone therapy to prevent recurrence .Post- menopausal women are prescribed drugs called Aromatase Inhibitors.
Aromatase Inhibitors are taken usually for 5 years and whilst considered highly effective in preventing recurrence of breast cancer do have the side effect of thinning bones and causing fractures. Administration of Denosumab injections(trade name Prolia) six monthly counteracts this effect and in addition further reduces recurrence of breast cancer significantly. http://www.breastcancer.org/research-news/prolia-reduces-recurrence-risk-for-some
Currently Prolia is only available on the PBS to women over 70 or those who have an existing fracture. The cost of Prolia to those unable to access the PBS price is high- $275 for each 6 monthly injection - and difficult for many to afford especially as the costs of breast cancer treatment has already been substantial.
Could not women suffering breast cancer who are placed on Aromatase Inhibitors -and at the outset of hormone therapy are osteoporotic as indicated by low T scores also be granted access to Prolia at the PBS price rather than wait to suffer the severe pain of a fracture and in addition receive the benefit of a further reduction in the risk of breast cancer recurrence this drug provides.